OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects Mediated by Dimethyl Fumarate on In Vitro Oligodendrocytes: Implications in Multiple Sclerosis
Claudia Guerriero, Giulia Puliatti, Tamara Di Marino, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3615-3615
Open Access | Times Cited: 7
Claudia Guerriero, Giulia Puliatti, Tamara Di Marino, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3615-3615
Open Access | Times Cited: 7
Showing 7 citing articles:
Assessment of the impact of reconstitution therapies—cladribine tablets and alemtuzumab—on the atrophy progression among patients with relapse-remitting multiple sclerosis
Aleksandra Pogoda-Wesołowska, Irene Stachura, Arkadiusz Żegadło, et al.
Frontiers in Neuroscience (2025) Vol. 19
Open Access
Aleksandra Pogoda-Wesołowska, Irene Stachura, Arkadiusz Żegadło, et al.
Frontiers in Neuroscience (2025) Vol. 19
Open Access
The Janus Face of Astrocytes in Multiple Sclerosis: Balancing Protection and Pathology
Ahmad Abulaban, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025), pp. 111356-111356
Open Access
Ahmad Abulaban, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Research Bulletin (2025), pp. 111356-111356
Open Access
Pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro
Larissa Jank, Riley B Catenacci, Veronica Minney, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00379-e00379
Open Access | Times Cited: 2
Larissa Jank, Riley B Catenacci, Veronica Minney, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00379-e00379
Open Access | Times Cited: 2
Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies
Antonietta Bernardo, Sergio Visentin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4596-4596
Open Access | Times Cited: 5
Antonietta Bernardo, Sergio Visentin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4596-4596
Open Access | Times Cited: 5
<i>In vitro</i> engineered models of neurodegenerative diseases
Zehra Gül Morçimen, Şeyma Taşdemir, Aylin Şendemir
Biocell (2024) Vol. 48, Iss. 1, pp. 79-96
Open Access
Zehra Gül Morçimen, Şeyma Taşdemir, Aylin Şendemir
Biocell (2024) Vol. 48, Iss. 1, pp. 79-96
Open Access
Understanding Multiple Sclerosis Pathophysiology and Current Disease-Modifying Therapies: A Review of Unaddressed Aspects
Eiman M. A. Mohammed
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 11
Open Access
Eiman M. A. Mohammed
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 11
Open Access
Multiple Sclerosis: New Insights into Molecular Pathogenesis and Novel Platforms for Disease Treatment
Majid Dejbakht, Morteza Akhzari, Sajad Jalili, et al.
Current Drug Research Reviews (2023) Vol. 16, Iss. 2, pp. 175-197
Closed Access
Majid Dejbakht, Morteza Akhzari, Sajad Jalili, et al.
Current Drug Research Reviews (2023) Vol. 16, Iss. 2, pp. 175-197
Closed Access
